Opioid Use Disorder

Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention. It is recognised that buprenorphine can alleviate opioid withdrawal...

Recent studies carried out by researchers from Vanderbilt University and Johns Hopkins University have examined characteristics linked with the heightened risk NAS. The researchers found that boys are more likely to receive a diagnosis of...

Opioid Use Disorder (OUD), and the associated risk of overdose and death, is becoming one of the most prevalent threats to health and social wellbeing in the United States. Medication, such as buprenorphine, is the gold standard treatment...

Emergency departments are often the first point of contact for individuals who have overdosed or suffering from the effects of opioids. Despite the vital role practitioners within this service provide, there has been, up until now, little...

ABSTRACT Background: Ibogaine is a monoterpene indole alkaloid used in medical and nonmedical settings for the treatment of opioid use disorder. Its mechanism of action is apparently novel. There are no published prospective studies of drug...

A webinar on opioid use disorder by Dr. Dennis McCarty is now available through the Addiction Technology Transfer Centre (ATTC) website. The hour long webinar took place in April 2018 and discusses treatment and prevention. The webinar...

Abstract Abuse-deterrent opioid formulations have been suggested as one way to decrease the abuse, addiction, and overdose of orally prescribed opioids. Ten oral opioid formulations have received abuse-deterrent labeling by the U.S. Food...